×
About 275 results

SEOM clinical guideline for the management of cutaneous melanoma (2020).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998
Clinical & Translational Oncology : Official Publication ... Majem M, Manzano JL et. al.

Mar 3rd, 2021 - Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of these patients. The diagnosis must be histological and determination of BRAF status has to be performed in patients with stage ≥ III. Stage I-III resec...

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage ...
https://doi.org/10.1200/JCO.20.03237
Journal of Clinical Oncology : Official Journal of the Am... Chen YP, Ismaila N et. al.

Jan 7th, 2021 - The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy for patients with stage II-IVA nasopharyngeal carcinoma (NPC). The Chinese Society of Clinical Oncology (CSCO) and ASCO convened an expert panel of radiation oncology, medical oncology, surgery, and advocacy representatives. ...

Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablat...
https://doi.org/10.1016/j.jvir.2019.11.004
Journal of Vascular and Interventional Radiology : JVIR; Gunn AJ, Parikh NS et. al.

Jan 10th, 2020 - Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation in Renal Cell Carcinoma.|2020|Gunn AJ,Parikh NS,Bhatia S,|diagnostic imaging,secondary,surgery,adverse effects,standards,diagnostic imaging,pathology,surgery,adverse effects,therapeutic use,standards,standards,adverse effects,standards,adverse effects,standards,

Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial...
https://doi.org/10.1002/jso.25797
Journal of Surgical Oncology REFERENCES; Ribeiro R, Fontes Cintra G et. al.

Dec 18th, 2019 - Approximately 70% of cancer-related deaths occur in low- and middle-income countries. In addition to social and racial inequalities, treatment options in these countries are usually limited because of the lack of trained staff and equipment, limited patient access to health services, and a small number of clinical guidelines. The Brazilian Society of Surgical Oncology developed this guideline t...

A Cancer Care Ontario Organizational Guideline for the Delivery of Stereotactic Radiosu...
https://doi.org/10.1016/j.prro.2019.11.002
Practical Radiation Oncology; Sahgal A, Kellett S et. al.

Nov 30th, 2019 - In Ontario, Canada, there is increasing demand for stereotactic radiosurgery (SRS) for brain metastases. Recommendations for safe SRS delivery are needed to ensure that patients receive an equitable level of care across the province. This guideline presents the minimal recommendations for the organization and delivery of SRS with respect to the multidisciplinary team, applicable technologies, i...

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
https://doi.org/10.1016/j.eururo.2019.02.011
European Urology; Ljungberg B, Albiges L et. al.

Feb 26th, 2019 - The European Association of Urology Renal Cell Carcinoma (RCC) Guideline Panel has prepared evidence-based guidelines and recommendations for the management of RCC. To provide an updated RCC guideline based on standardised methodology including systematic reviews, which is robust, transparent, reproducible, and reliable. For the 2019 update, evidence synthesis was undertaken based on a comprehe...

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver me...
https://doi.org/10.1007/s00432-018-2795-1
Journal of Cancer Research and Clinical Oncology; Xu J, Fan J et. al.

Dec 14th, 2018 - The liver is the most common anatomical site for hematogenous metastases of colorectal cancer, and colorectal liver metastases is one of the most difficult and challenging points in the treatment of colorectal cancer. To improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised several times since 2008, including the overall evaluation, personalized...

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
https://doi.org/10.6004/jnccn.2018.0079
Journal of the National Comprehensive Cancer Network : JN... Kalemkerian GP, Loo BW et. al.

Oct 17th, 2018 - The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis,...
https://doi.org/10.1093/annonc/mdy275
Annals of Oncology : Official Journal of the European Soc... Planchard D, Popat S et. al.

Oct 1st, 2018 - Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2018|Planchard D,Popat S,Kerr K,Novello S,Smit EF,|epidemiology,secondary,therapy,epidemiology,pathology,therapy,standards,standards,standards,

SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder can...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515768
World Journal of Urology; Merseburger AS, Apolo AB et. al.

Sep 22nd, 2018 - The SIU (Société Internationale d'Urologie)-ICUD (International Consultation on Urologic Diseases) working group on systemic therapy for metastatic bladder cancer has summarized the most recent findings on the aforementioned topic and came to conclusions and recommendations according to the evidence published. In Europe and the United States, treatment for metastatic UC has changed a great deal...

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth...
https://doi.org/10.1200/JCO.2018.79.2713
Journal of Clinical Oncology : Official Journal of the Am... Ramakrishna N, Temin S et. al.

Jun 26th, 2018 - Purpose To update the formal expert consensus-based guideline recommendations for practicing oncologists and others on the management of brain metastases for patients with human epidermal growth factor receptor 2-positive advanced breast cancer to 2018. Methods An Expert Panel conducted a targeted systematic literature review (for both systemic treatment and CNS metastases) and identified 622 a...

Consensus statement on essential patient characteristics in systemic treatment trials f...
https://doi.org/10.1016/j.ejca.2018.05.010
European Journal of Cancer (Oxford, England : 1990); Goey KKH, Sørbye H et. al.

Jun 25th, 2018 - Patient characteristics and stratification factors are key features influencing trial outcomes. However, there is substantial heterogeneity in reporting of patient characteristics and use of stratification factors in phase 3 trials investigating systemic treatment of metastatic colorectal cancer (mCRC). We aimed to develop a minimum set of essential baseline characteristics and stratification f...

Elderly patients with metastatic renal cell carcinoma: position paper from the Internat...
https://doi.org/10.1016/S1470-2045(18)30125-6
The Lancet. Oncology; Kanesvaran R, Le Saux O et. al.

Jun 13th, 2018 - Therapy for metastatic renal cell carcinoma should be tailored to the circumstances and preferences of the individual patient. Age should not be a barrier to effective treatment. Systematic geriatric screening and assessment contributes to the goal of personalised management, in addition to the involvement of a multidisciplinary team. A task force from the International Society of Geriatric Onc...

New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distan...
https://doi.org/10.6004/jnccn.2018.0042
Journal of the National Comprehensive Cancer Network : JN... Barker CA, Salama AK

May 23rd, 2018 - The NCCN Guidelines Panel for Melanoma debuted new guidelines for uveal melanoma at the NCCN 23rd Annual Conference. Although uveal melanoma and cutaneous melanoma share the same name, they do have different characteristics and treatments. The NCCN Guidelines describe how tumor size guides therapeutic options, which for most tumors is radiotherapy. Predictors of melanoma-related mortality inclu...

Guidelines of care for the management of basal cell carcinoma.
https://doi.org/10.1016/j.jaad.2017.10.006
Journal of the American Academy of Dermatology; , et. al.

Jan 15th, 2018 - Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of...

Guidelines of care for the management of cutaneous squamous cell carcinoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652228
Journal of the American Academy of Dermatology; , et. al.

Jan 15th, 2018 - Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include b...

Clinical trial design for systemic agents in patients with brain metastases from solid ...
https://doi.org/10.1016/S1470-2045(17)30693-9
The Lancet. Oncology; Camidge DR, Lee EQ et. al.

Jan 6th, 2018 - Patients with active CNS disease are often excluded from clinical trials, and data regarding the CNS efficacy of systemic agents are usually obtained late in the drug development process or not at all. In this guideline from the Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group, we provide detailed recommendations on when patients with brain metastases from solid tu...

Clinical trial design for local therapies for brain metastases: a guideline by the Resp...
https://doi.org/10.1016/S1470-2045(17)30692-7
The Lancet. Oncology; Alexander BM, Brown PD et. al.

Jan 6th, 2018 - The goals of therapeutic and biomarker development form the foundation of clinical trial design, and change considerably from early-phase to late-phase trials. From these goals, decisions on specific clinical trial design elements, such as endpoint selection and statistical approaches, are formed. Whereas early-phase trials might focus on finding a therapeutic signal to make decisions on furthe...

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clini...
https://doi.org/10.1200/JOP.2017.027672
Journal of Oncology Practice; Van Poznak C, Somerfield MR et. al.

Oct 17th, 2017 - Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary.|2017|Van Poznak C,Somerfield MR,Moy B,|therapeutic use,drug therapy,secondary,drug therapy,pathology,therapeutic use,standards,drug therapy,therapeutic use,therapeutic use,

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clini...
https://doi.org/10.1200/JCO.2017.75.4614
Journal of Clinical Oncology : Official Journal of the Am... Van Poznak C, Somerfield MR et. al.

Oct 17th, 2017 - Purpose To update, in collaboration with Cancer Care Ontario (CCO), key recommendations of the American Society of Clinical Oncology (ASCO) guideline on the role of bone-modifying agents (BMAs) in metastatic breast cancer. This focused update addressed the new data on intervals between dosing and the role of BMAs in control of bone pain. Methods A joint ASCO-CCO Update Committee conducted targe...